Showing results (1521-1530 of 1,852) with videos related to

Sort By:
Pageof 186
The EMBO Journal|January 27, 2006
Growth factor pleiotropy is controlled by a receptor Tyr/Ser motif that acts as a binary switchMark A Guthridge, Jason A Powell, Emma F Barry, et al.
AIDS Care|February 12, 2014
The HIV basic care package: where is it available and who receives it? Findings from a mixed methods evaluation in Kenya and UgandaSuzanne Penfold, Victoria Simms, Julia Downing, et al.
Molecular Cell|November 14, 2021
Balancing of mitochondrial translation through METTL8-mediated m<sup>3</sup>C modification of mitochondrial tRNAsEva Schöller, James Marks, Virginie Marchand, et al.
Genomics|September 6, 2002
Sequencing, transcript identification, and quantitative gene expression profiling in the breast cancer loss of heterozygosity region 16q24.3 reveal three potential tumor-suppressor genesJason A Powell, Alison E Gardner, Anthony J Bais, et al.
Gynecologic Oncology Reports|May 8, 2019
Do gynecologic oncology patients with severely diminished renal function and urinary tract obstruction benefit from ureteral stenting or percutaneous nephrostomy?Brooke Liang, Sara S Lange, L Stewart Massad, et al.
Cancer Research|January 10, 2015
RAGE mediates S100A7-induced breast cancer growth and metastasis by modulating the tumor microenvironmentMohd W Nasser, Nissar Ahmad Wani, Dinesh K Ahirwar, et al.
Gynecologic Oncology|January 21, 2020
Second-line lenvatinib in patients with recurrent endometrial cancerIgnace Vergote, Matthew A Powell, Michael G Teneriello, et al.
Annals of the American Thoracic Society|May 21, 2021
Lung Cancer Risk among Patients with Asthma-Chronic Obstructive Pulmonary Disease OverlapAntonios Charokopos, Sidney S Braman, Stacey A Whittaker Brown, et al.
Journal of Structural Biology|January 17, 2012
Engineering human MEK-1 for structural studies: A case study of combinatorial domain huntingChristoph Meier, Daniel C Brookings, Thomas A Ceska, et al.
Cancer Research|June 17, 2010
Essential requirement for PP2A inhibition by the oncogenic receptor c-KIT suggests PP2A reactivation as a strategy to treat c-KIT+ cancersKathryn G Roberts, Amanda M Smith, Fiona McDougall, et al.
Pageof 186